The United States contributes significantly to the North American colistin market through its advanced hospital network, pharmaceutical research activities, and focus on combating drug-resistant infections. Colistin remains an important treatment option in selected cases involving serious infections caused by multidrug-resistant Gram-negative bacteria when other suitable antibiotics are...